BioSpace News Archive

Business

UH Cancer Researcher Focused on Tumor Development Research Aims to Preempt Cancer by Targeting Precursor Lesions

A cancer researcher at the University of Houston is set to deliver an unprecedented look at the 20-year development of esophageal cancer that starts with a precancerous lesion known as “Barrett’s esophagus.”

December 6, 2017

·

4 min read

Deals

Advanced Accelerator Applications Board of Directors Recommends $3.9B All Cash Tender Offer by Novartis

The transaction is subject to customary transactional regulatory approvals.

December 6, 2017

·

8 min read

Deals

Indalo Therapeutics Formed by Merger of Antegrin and Cascadia

Financial terms of the deal were not disclosed.

December 6, 2017

·

3 min read

Biotech Beach

Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of Neratinib in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 San Antonio Breast Cancer Symposium

The presentation entitled, “Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2-positive early stage breast cancer: the CONTROL trial,” will be presented at a poster session on December 7 at 5:00 p.m. CST.

December 6, 2017

·

11 min read

Rhythmlink Launches FDA Cleared MR Conditional*/CT Quick Connect System Product Line

Rhythmlink announced the release of a new product line designed to maximize efficiency and workflow when recording EEG on patients who require MR or CT imaging.

December 6, 2017

·

4 min read

Business

CanniMed Therapeutics Announces Medical Cannabis Supply Agreement with PharmaChoice

Pursuant to the agreement, PharmaChoice has committed exclusively to CanniMed as its sole supplier of cannabis products, subject to CanniMed meeting certain product and volume requirements.

December 6, 2017

·

5 min read

Critical Outcome Technologies Annual and Special Meeting of Shareholders Rescheduled

Critical Outcome Technologies announced a change in the previously set date for the Company’s Annual and Special Meeting of Shareholders (the “Meeting”), which was originally scheduled for Thursday, December 7, 2017 at 9:30 a.m. Eastern Standard Time.

December 6, 2017

·

2 min read

Business

Vernalis and Servier Achieve Research Milestone

Vernalis will receive a payment of EUR 1.0m from Servier in recognition of this achievement.

December 6, 2017

·

5 min read

Business

Novasep Invests €17M in its Dedicated cGMP Monoclonal Antibody (mAb) Production Facility

Novasep announces a EUR17M investment in a dedicated GMP mAb production facility.

December 6, 2017

·

2 min read

Business

TapImmune Appoints Richard Kenney, M.D., F.A.C.P., as Acting CMO

In this newly created role at TapImmune, Dr. Kenney will continue to manage the Company’s ongoing and planned clinical programs for its novel, multi-epitope, T-cell vaccine candidates.

December 6, 2017

·

5 min read